Found: 32
Select item for more details and to access through your institution.
Umbilical cord blood transplantation: Still growing and improving.
- Published in:
- Stem Cells Translational Medicine, 2021, v. 10, p. S62, doi. 10.1002/sctm.20-0495
- By:
- Publication type:
- Article
Inflammatory monocytes promote pre-engraftment syndrome and tocilizumab can therapeutically limit pathology in patients.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24412-1
- By:
- Publication type:
- Article
Treating Relapsed/Refractory Acute Myeloid Leukemia with Chidamide, Fludarabine, Cytarabine and Granulocyte-Colony Stimulating Factor with Subsequent Bridging to Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2022, v. 14, n. 1, p. 1, doi. 10.4084/MJHID.2022.025
- By:
- Publication type:
- Article
Donor KIR3DL1/receptor HLA-Bw4-80I Combination Reduces Acute Leukemia Relapse after Umbilical Cord Blood Transplantation without in Vitro T-cell Depletion.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2021, v. 13, n. 1, p. 1, doi. 10.4084/MJHID.2021.005
- By:
- Publication type:
- Article
Letermovir prophylaxis reduced cytomegalovirus reactivation and resistance post umbilical cord blood transplantation.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 6, p. 2378, doi. 10.1111/bjh.19451
- By:
- Publication type:
- Article
The clinical influence of preformed nonspecific anti‐HLA antibodies on single‐unit umbilical cord blood transplantation in patients with haematological malignancies.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 4, p. e63, doi. 10.1111/bjh.18316
- By:
- Publication type:
- Article
The incidence, risk factors and outcomes of early bloodstream infection in patients with malignant hematologic disease after unrelated cord blood transplantation: a retrospective study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Allogeneic double‐negative T cell therapy for relapsed acute myeloid leukemia patients post allogeneic hematopoietic stem cell transplantation: A first‐in‐human phase I study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. E264, doi. 10.1002/ajh.26564
- By:
- Publication type:
- Article
Pretreatment of unrelated umbilical cord blood transplantation without antithymocyte globulin for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia: follow-up evaluation of 306 cases.
- Published in:
- Chinese Journal of Tissue Engineering Research / Zhongguo Zuzhi Gongcheng Yanjiu, 2020, v. 24, n. 31, p. 4986, doi. 10.3969/j.issn.2095-4344.2141
- By:
- Publication type:
- Article
Umbilical cord blood transplantation can overcome the poor prognosis of KMT2A-MLLT3 acute myeloid leukemia and can lead to good GVHD-free/relapse-free survival.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 5, p. 1303, doi. 10.1007/s00277-021-04413-2
- By:
- Publication type:
- Article
Pre-engraftment bloodstream infections in acute leukemia patients undergoing unrelated cord blood transplantation following intensified myeloablative conditioning without ATG.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comparative analysis of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation in children with high-risk or advanced acute leukemia.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 3, p. 473, doi. 10.1007/s00277-014-2213-y
- By:
- Publication type:
- Article
Unrelated cord blood transplantation for central nervous system relapse in high-risk childhood acute lymphoblastic leukemia.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 12, p. 1665, doi. 10.1007/s00277-013-1820-3
- By:
- Publication type:
- Article
Decitabine prior to salvaged unrelated cord blood transplantation for refractory or relapsed childhood acute leukemia.
- Published in:
- Pediatric Transplantation, 2016, v. 20, n. 8, p. 1117, doi. 10.1111/petr.12805
- By:
- Publication type:
- Article
Successful second transplantation with non-myeloablative conditioning using haploidentical donors for young patients after graft failure following double umbilical cord cell transplantation.
- Published in:
- Pediatric Transplantation, 2010, v. 14, n. 4, p. 465, doi. 10.1111/j.1399-3046.2009.01231.x
- By:
- Publication type:
- Article
Decitabine prior to salvaged cord blood transplantation for acute myeloid leukaemia/myelodysplastic syndrome not in remission.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 6, p. 1372, doi. 10.1111/jcpt.13231
- By:
- Publication type:
- Article
All-trans retinoic acid 45 mg/m2 is superior to 25 mg/m2 as the first induction regimen for the treatment of acute promyelocytic leukaemia: a retrospective analysis in a real-world clinical setting.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-021-00411-9
- By:
- Publication type:
- Article
Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 3, p. 699, doi. 10.1002/ijc.31339
- By:
- Publication type:
- Article
Extensively drug-resistant Gram-negative bacterial bloodstream infection in hematological disease.
- Published in:
- Infection & Drug Resistance, 2019, v. 12, p. 481, doi. 10.2147/IDR.S191462
- By:
- Publication type:
- Article
Incidence and risk factors of late-onset hemorrhagic cystitis after single umbilical cord blood transplantation with myeloablative conditioning regimen.
- Published in:
- International Journal of Hematology, 2021, v. 114, n. 3, p. 381, doi. 10.1007/s12185-021-03168-w
- By:
- Publication type:
- Article
Poor survival and prediction of prolonged isolated thrombocytopenia post umbilical cord blood transplantation in patients with hematological malignancies.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 1, p. 82, doi. 10.1002/hon.2937
- By:
- Publication type:
- Article
Cytomegalovirus-Specific T Cells from Third-Party Donors Successfully Treated Refractory Cytomegalovirus Retinitis after Unrelated Umbilical Cord Blood Transplantation.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Impact Of ELN Risk Stratification, Induction Chemotherapy Regimens And Hematopoietic Stem Cell Transplantation On Outcomes In Hyperleukocytic Acute Myeloid Leukemia With Initial White Blood Cell Count More Than 100 × 109/L.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 9495, doi. 10.2147/CMAR.S225123
- By:
- Publication type:
- Article
High-dose cytarabine monotherapy is superior to standard-dose cytarabine-based multiagent sequential treatment cycle for consolidation treatment in adult (14-59 years) AML patients according to European Leukemia Net 2022 risk stratification.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 01, doi. 10.3389/fonc.2022.1070588
- By:
- Publication type:
- Article
A comparative study of idarubicin 12 mg/m<sup>2</sup> and 8 mg/m<sup>2</sup> combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 985, doi. 10.2147/OTT.S96176
- By:
- Publication type:
- Article
Outcomes of Adolescents and Young Adults Compared with Children with Acute Leukemia after Single-Unit Unrelated Cord Blood Transplantation Using Myeloablative Conditioning without Antithymocyte Globulin.
- Published in:
- Acta Haematologica, 2021, v. 144, n. 5, p. 569, doi. 10.1159/000507973
- By:
- Publication type:
- Article
Refining eligibility criteria of unit selection for myeloablative cord blood transplantation in acute leukemia: Real‐world experience of a referral center.
- Published in:
- EJHaem, 2023, v. 4, n. 2, p. 470, doi. 10.1002/jha2.703
- By:
- Publication type:
- Article
Clinical outcome of cord blood transplantation for nine children with juvenile myelomonocytic leukemia receiving fludarabine‐busulfan‐cyclophosphamide‐based conditioning.
- Published in:
- Pediatric Transplantation, 2022, v. 26, n. 2, p. 1, doi. 10.1111/petr.14181
- By:
- Publication type:
- Article
Effects and long‐term follow‐up of using umbilical cord blood–derived mesenchymal stromal cells in pediatric patients with severe BK virus‐associated late‐onset hemorrhagic cystitis after unrelated cord blood transplantation.
- Published in:
- Pediatric Transplantation, 2020, v. 24, n. 2, p. 1, doi. 10.1111/petr.13618
- By:
- Publication type:
- Article
Standard-Intensity Induction and Intermediate/High-Dose Cytarabine Consolidation Can Improve Survival for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Cohort Study.
- Published in:
- Clinical Interventions in Aging, 2022, v. 17, p. 55, doi. 10.2147/CIA.S343598
- By:
- Publication type:
- Article
A predictive model combining clinical characteristics and nutritional risk factors for overall survival after umbilical cord blood transplantation.
- Published in:
- Stem Cell Research & Therapy, 2023, v. 14, n. 1, p. 1, doi. 10.1186/s13287-023-03538-7
- By:
- Publication type:
- Article
Unrelated cord blood transplantation vs. HLA-matched sibling transplantation for adults with B-cell acute lymphoblastic leukemia in complete remission: superior OS for patients with long-term survival.
- Published in:
- Stem Cell Research & Therapy, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13287-022-03186-3
- By:
- Publication type:
- Article